Literature DB >> 17431220

Electrical parameters and ion species for active transport in human esophageal stratified squamous epithelium and Barrett's specialized columnar epithelium.

N A Tobey1, C M Argote, X C Vanegas, W Barlow, R C Orlando.   

Abstract

The human esophagus is lined by stratified squamous epithelium (ESSE), and in some subjects with reflux disease the distal esophagus becomes lined by Barrett's specialized columnar epithelium (BSCE). ESSE and BSCE differ both histologically and functionally, the latter evident by differences in their in vivo transmural electrical potential difference (PD), ESSE averaging -15 mV and BSCE being greater than -25 mV. In this report we examine the basis for this difference in PD. This is done by mounting endoscopic biopsies of ESSE from 25 subjects without esophageal disease and BSCE from 19 with Barrett's esophagus in mini-Ussing chambers for electrical recordings basally and after bathing solution ion replacement. The results show that the PD of human ESSE reflects a low level of active ion transport (5.1 +/- 0.8 muA/cm(2)) combined with a high level of tissue (electrical) resistance (344 +/- 34 Omega.cm(2)) and that of BSCE reflects a high level of active transport (43.6 +/- 11.6 muA/cm(2)) combined with a low level of resistance (69 +/- 8 Omega.cm(2)). Furthermore, active transport in ESSE was principally due to sodium absorption whereas in BSCE it was equally divided between sodium absorption and anion (chloride/bicarbonate) secretion, the latter through an apical membrane, 4-acetamido4'-isothiocyano-2,2'-stilbenedisulfonic acid-sensitive anion channel. As an anion-secreting tissue with bicarbonate secretory capacity more than fivefold greater than ESSE, BSCE is better suited than ESSE for defense of the esophagus against reflux disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431220     DOI: 10.1152/ajpgi.00047.2007

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  22 in total

Review 1.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 2.  New models of neoplastic progression in Barrett's oesophagus.

Authors:  Kirill Pavlov; Carlo C Maley
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

3.  Evaluating the Esophageal Epithelial Integrity: More Complex than it Seems.

Authors:  Ricard Farré
Journal:  Am J Gastroenterol       Date:  2016-02       Impact factor: 10.864

4.  New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management.

Authors:  Brian J Reid; Rumen Kostadinov; Carlo C Maley
Journal:  Clin Cancer Res       Date:  2011-04-15       Impact factor: 12.531

5.  Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease.

Authors:  Biljana Jovov; Jianwen Que; Nelia A Tobey; Zorka Djukic; Brigid L M Hogan; Roy C Orlando
Journal:  Am J Gastroenterol       Date:  2011-03-29       Impact factor: 10.864

Review 6.  Esophageal Impedance Monitoring: Clinical Pearls and Pitfalls.

Authors:  Karthik Ravi; David A Katzka
Journal:  Am J Gastroenterol       Date:  2016-06-21       Impact factor: 10.864

7.  Residual embryonic cells as precursors of a Barrett's-like metaplasia.

Authors:  Xia Wang; Hong Ouyang; Yusuke Yamamoto; Pooja Ashok Kumar; Tay Seok Wei; Rania Dagher; Matthew Vincent; Xin Lu; Andrew M Bellizzi; Khek Yu Ho; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-06-24       Impact factor: 41.582

Review 8.  The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms.

Authors:  Roy C Orlando
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-12       Impact factor: 3.043

9.  Defective barrier function in neosquamous epithelium.

Authors:  Biljana Jovov; Nicholas J Shaheen; Geraldine S Orlando; Zorka Djukic; Roy C Orlando
Journal:  Am J Gastroenterol       Date:  2013-01-15       Impact factor: 10.864

10.  Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity.

Authors:  Heather D Kissel; Patricia C Galipeau; Xiaohong Li; Brian J Reid
Journal:  Cancer Biomark       Date:  2009       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.